TIZIANA LIFE SCIENCES LTD (TLSA:NASDAQ)
$1.23 -0.03 (-2.381%)
Analysed TIZIANA LIFE SCIENCES LTD (TLSA:NASDAQ) News Sources
Tiziana Life Sciences price target boosted on foralumab update
19-05-2026
proactiveinvestors.com
Sector Update: Healthcare Stocks Gain Late Afternoon
19-05-2026
yahoo.com
Tiziana Fully Enrolls its Phase 2 Placebo Controlled Multiple Sclerosis Trial
21-05-2026
yahoo.com
Tiziana Life Sciences completes enrollment in Phase 2a multiple sclerosis trial
21-05-2026
proactiveinvestors.com
Tiziana Life Sciences advances foralumab program with full Phase 2 enrollment and encouraging expanded access data – ICYMI
22-05-2026
proactiveinvestors.com
Tiziana Life Sciences to Present at the Jefferies Global Healthcare Conference in New York
28-05-2026
yahoo.com
Innoviva Stock Is Up Just 10% This Past Year. Here's Why a Fund Bought $2.5 Million More
29-05-2026
fool.com
Tiziana Life Sciences Announces Purchase of Shares by Executive Chairman
15-06-2026
yahoo.com
Tiziana Announces Last Patient Successfully Dosed in its Phase 2 INFORM-MS Trial
25-06-2026
yahoo.com
Tiziana Life Sciences doses last patient in Phase 2a multiple sclerosis trial
25-06-2026
proactiveinvestors.com
What is the current price of TIZIANA LIFE SCIENCES LTD (TLSA:NASDAQ)?
The current price of TIZIANA LIFE SCIENCES LTD (TLSA:NASDAQ) is $1.23.
TIZIANA LIFE SCIENCES LTD (TLSA:NASDAQ) absolute price change since previous trading day?
The absolute price change of TIZIANA LIFE SCIENCES LTD (TLSA:NASDAQ) since the previous trading day is $-0.03.
TIZIANA LIFE SCIENCES LTD (TLSA:NASDAQ) percentage price change since previous trading day?
The percentage price change of TIZIANA LIFE SCIENCES LTD (TLSA:NASDAQ) since the previous trading day is -2.381%.
What is the most recent average sentiment score for TIZIANA LIFE SCIENCES LTD (TLSA:NASDAQ)?
The most recent average sentiment score for TIZIANA LIFE SCIENCES LTD (TLSA:NASDAQ) is 80 out of 100.
What is the most recent average sentiment for TIZIANA LIFE SCIENCES LTD (TLSA:NASDAQ)?
The most recent sentiment for TIZIANA LIFE SCIENCES LTD (TLSA:NASDAQ) is .
SEC-8K** Filing Available For TIZIANA LIFE SCIENCES LTD (TLSA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.